Schering-Plough’s “Build The Base” Action Agenda May Include Acquisitions
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm announces it is moving into the fourth phase of its five-point action agenda restructuring plan.
You may also be interested in...
Schering-Plough CEO Fred Hassan: An Interview With “The Pink Sheet” DAILY (Part 2 of 3)
Hassan discusses changes in the industry, the importance of emerging markets such as Asia, the debate over follow-on biologics and the PDUFA reauthorization.
Schering-Plough CEO Fred Hassan: An Interview With “The Pink Sheet” DAILY (Part 2 of 3)
Hassan discusses changes in the industry, the importance of emerging markets such as Asia, the debate over follow-on biologics and the PDUFA reauthorization.
Schering-Plough Makes Its Move, Snapping Up Organon For $14.4 Billion
After much talk of a major acquisition, Schering buys the Organon pharmaceutical and animal health business of Akzo Nobel.